Aligos Therapeutics, Inc. · NASDAQ:ALGS
Adage Capital Management, L.P. reported a 9.38% stake in Aligos Therapeutics, Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Adage Capital Management, L.P. reported a 9.38% stake in Aligos Therapeutics, Inc., 325,000 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 9.38%
- Shares
- 325,000
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 9.38% | 325,000 |
| Robert Atchinson | 9.38% | 325,000 |
| Phillip Gross | 9.38% | 325,000 |
Source
Related
- Aligos Therapeutics, Inc.
- Adage Capital Management, L.P.
- Aligos Therapeutics, Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2025
- Schedule 13D · Lawrence M. Blatt · Jun 24, 2026
- Schedule 13G/A · Woodline Partners LP · May 15, 2026
- Schedule 13G · Lawrence M. Blatt · May 15, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Sio Capital Management, LLC · Feb 11, 2026